Mason KA - Search Results

1

Combination of taxanes with radiation: preclinical studies.

Milas L, Milas MM, Mason KA. Milas L, et al. Among authors: mason ka. Semin Radiat Oncol. 1999 Apr;9(2 Suppl 1):12-26. Semin Radiat Oncol. 1999. PMID: 10210536 Review.

2

Inhibition of P-TEFb by DRB suppresses SIRT1/CK2α pathway and enhances radiosensitivity of human cancer cells.

Wang ZQ, Johnson CL, Kumar A, Molkentine DP, Molkentine JM, Rabin T, Mason KA, Milas L, Raju U. Wang ZQ, et al. Among authors: mason ka. Anticancer Res. 2014 Dec;34(12):6981-9. Anticancer Res. 2014. PMID: 25503124

3

Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.

Raju U, Molkentine DP, Valdecanas DR, Deorukhkar A, Mason KA, Buchholz TA, Meyn RE, Ang KK, Skinner H. Raju U, et al. Among authors: mason ka. Cancer Med. 2015 Jan;4(1):65-74. doi: 10.1002/cam4.345. Epub 2014 Oct 30. Cancer Med. 2015. PMID: 25355701 Free PMC article.

4

The impact of timing of EGFR and IGF-1R inhibition for sensitizing head and neck cancer to radiation.

Matsumoto F, Valdecanas DN, Mason KA, Milas L, Ang KK, Raju U. Matsumoto F, et al. Among authors: mason ka. Anticancer Res. 2012 Aug;32(8):3029-35. Anticancer Res. 2012. PMID: 22843870

5

Poly (ADP-ribose) polymerase inhibitors in cancer treatment.

Mason KA, Raju U, Buchholz TA, Wang L, Milas ZL, Milas L. Mason KA, et al. Am J Clin Oncol. 2014 Feb;37(1):90-100. doi: 10.1097/COC.0b013e3182467dce. Am J Clin Oncol. 2014. PMID: 22495455 Review.

6

INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase, enhances tumor response to doxorubicin.

Mason KA, Valdecanas D, Hunter NR, Milas L. Mason KA, et al. Invest New Drugs. 2008 Feb;26(1):1-5. doi: 10.1007/s10637-007-9072-5. Epub 2007 Jul 13. Invest New Drugs. 2008. PMID: 17628743

7

Preclinical biologic assessment of proton beam relative biologic effectiveness at Proton Therapy Center Houston.

Mason KA, Gillin MT, Mohan R, Cox JD. Mason KA, et al. Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):968-70. doi: 10.1016/j.ijrobp.2007.03.051. Epub 2007 May 23. Int J Radiat Oncol Biol Phys. 2007. PMID: 17512131

8

Modulation of tumor radiation response with G3139, a bcl-2 antisense oligonucleotide.

Wiedenmann N, Koto M, Raju U, Milas L, Mason KA. Wiedenmann N, et al. Among authors: mason ka. Invest New Drugs. 2007 Oct;25(5):411-6. doi: 10.1007/s10637-007-9058-3. Epub 2007 May 11. Invest New Drugs. 2007. PMID: 17492397

9

Combination of radiotherapy with EGFR antagonists for head and neck carcinoma.

Thariat J, Yildirim G, Mason KA, Garden AS, Milas L, Ang KK. Thariat J, et al. Among authors: mason ka. Int J Clin Oncol. 2007 Apr;12(2):99-110. doi: 10.1007/s10147-006-0663-5. Epub 2007 Apr 27. Int J Clin Oncol. 2007. PMID: 17443277 Review.

10

Cyclo-oxygenase-2 and its inhibition in cancer: is there a role?

Liao Z, Mason KA, Milas L. Liao Z, et al. Among authors: mason ka. Drugs. 2007;67(6):821-45. doi: 10.2165/00003495-200767060-00001. Drugs. 2007. PMID: 17428102 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results